Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00321737 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

445

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophagitis, Reflux
Esophagitis, Peptic

Interventions

DRUG: Dexlansoprazole MR
DRUG: Dexlansoprazole MR
DRUG: Placebo

Sponsor

Takeda